drugset / Trial / NCT04838145

The Diabetes Virus Detection and Intervention Trial

NCT04838145 ↗

Phase 2 Completed 96 enrolled Oslo University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized, double-blind, placebo-controlled study in 96 children and adolescents age 6-15 newly diagnosed with type 1 diabetes to describe the influence of antiviral treatment (Pleconaril and Ribavirin) on progression of disease and residual insulin secretion.

Timeline

Start
2018-08-30
Primary completion
2020-10-25
Completion
2020-10-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pleconaril Small molecule 5 mg/kg Oral
Comparator Ribavirin Small molecule 7.5 mg/kg Oral